Charity gives life to languishing drugs.
As part of an innovative profit-sharing program, Cancer Research UK has been partnering with industry to bring sidelined and novel drugs into clinical trials for cancer. In December, the charity announced its ninth such partnership since 2007-an agreement with AstraZeneca to take the experimental asthma drug AZD2098 into a clinical trial for kidney cancer.